Australia markets close in 1 hour 27 minutes

Tonix Pharmaceuticals Holding Corp. (TNXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1570-0.0024 (-1.51%)
At close: 04:00PM EDT
0.1548 -0.00 (-1.40%)
After hours: 07:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 14.81M
Enterprise value -325.71k
Trailing P/E 0.29
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.34
Price/book (mrq)0.14
Enterprise value/revenue -0.04
Enterprise value/EBITDA 0.00

Trading information

Stock price history

Beta (5Y monthly) 2.23
52-week change 3-94.67%
S&P500 52-week change 321.23%
52-week high 33.3125
52-week low 30.1200
50-day moving average 30.2988
200-day moving average 30.6253

Share statistics

Avg vol (3-month) 32.2M
Avg vol (10-day) 33.57M
Shares outstanding 595.54M
Implied shares outstanding 695.54M
Float 884.49M
% held by insiders 10.01%
% held by institutions 119.85%
Shares short (28 Mar 2024) 41.25M
Short ratio (28 Mar 2024) 40.52
Short % of float (28 Mar 2024) 41.70%
Short % of shares outstanding (28 Mar 2024) 41.70%
Shares short (prior month 29 Feb 2024) 4616.24k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 301 Nov 2019
Ex-dividend date 4N/A
Last split factor 216:100
Last split date 310 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-723.18%

Management effectiveness

Return on assets (ttm)-38.93%
Return on equity (ttm)-74.61%

Income statement

Revenue (ttm)7.77M
Revenue per share (ttm)0.46
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -114.09M
Net income avi to common (ttm)-116.66M
Diluted EPS (ttm)-6.8500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)24.95M
Total cash per share (mrq)0.29
Total debt (mrq)9.81M
Total debt/equity (mrq)9.30%
Current ratio (mrq)2.53
Book value per share (mrq)1.80

Cash flow statement

Operating cash flow (ttm)-102M
Levered free cash flow (ttm)-82M